Maria Kiraly - CIG PANNONIA Chairman of the Board
0CKA Stock | EUR 0.96 0.03 3.23% |
Insider
Maria Kiraly is Chairman of the Board of CIG PANNONIA LIFE since 2014.
Tenure | 11 years |
Phone | 36 1 510 0200 |
Web | http://www.cigpannonia.hu |
Similar Executives
Showing other executives | INSIDER Age | ||
Peter Eriksson | Indutrade AB | 70 | |
KlausGerd Kleversaat | Tradegate AG Wertpapierhandelsb | N/A | |
Anna BSc | Diamyd Medical AB | 62 | |
Patrik Stolpe | Indutrade AB | 58 | |
Holger Timm | Tradegate AG Wertpapierhandelsb | N/A | |
Joakim MSc | Indutrade AB | 56 | |
Eva Karlstrom | Diamyd Medical AB | 59 | |
Martina Widman | Diamyd Medical AB | 42 | |
Susann Nyberg | Indutrade AB | 60 | |
Marten Svanberg | Indutrade AB | N/A | |
Asa Wirsenius | Indutrade AB | 46 | |
Juha Kujala | Indutrade AB | 56 | |
Ulf MBA | Diamyd Medical AB | 48 | |
Bo MSc | Indutrade AB | 58 | |
Karsten Haesen | Tradegate AG Wertpapierhandelsb | N/A | |
Thorsten Commichau | Tradegate AG Wertpapierhandelsb | N/A | |
Gte Mattsson | Indutrade AB | 68 | |
Jorg Hartmann | Tradegate AG Wertpapierhandelsb | N/A | |
Patrik Johnson | Indutrade AB | 53 | |
Christoph Nowak | Diamyd Medical AB | 37 | |
Anton Lindqvist | Diamyd Medical AB | 43 |
Management Performance
Return On Equity | 0.16 | |||
Return On Asset | 0.0097 |
CIG PANNONIA LIFE Leadership Team
Elected by the shareholders, the CIG PANNONIA's board of directors comprises two types of representatives: CIG PANNONIA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CIG. The board's role is to monitor CIG PANNONIA's management team and ensure that shareholders' interests are well served. CIG PANNONIA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CIG PANNONIA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gergely Horvath, Director | ||
Istvan Papp, Member of the Supervisory Board | ||
Katalin Halasz, Chief Medical Officer | ||
Istvan Boros, Member of the Supervisory Board | ||
Miklos Barta, Deputy Chief Executive Officer, Chief Financial Officer, Director | ||
Gyula Miko, Director | ||
Imre Pinter, Compliance Officer | ||
Gabriella Kadar, Chief Executive Officer, Director | ||
Maria Kiraly, Chairman of the Board | ||
Antal Csevar, Chief Legal Advisor, Consumer and Data Protection Officer | ||
Imrene Fekete, Member of the Supervisory Board | ||
Jozsef Bayer, Chairman of the Supervisory Board | ||
Pal Buzas, Chief Risk Officer | ||
Tibor Edvi, Chief Actuary | ||
Erika Marczi, Internal Auditor | ||
Erzsebet Czako, Member of the Supervisory Board |
CIG Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CIG PANNONIA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.16 | |||
Return On Asset | 0.0097 | |||
Profit Margin | 0.05 % | |||
Shares Outstanding | 94.43 M | |||
Gross Profit | 3.86 B | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 33.97 X | |||
Earnings Per Share | 0.05 X | |||
Target Price | 410.0 | |||
Number Of Employees | 191 |
Currently Active Assets on Macroaxis
Other Information on Investing in CIG Stock
CIG PANNONIA financial ratios help investors to determine whether CIG Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CIG with respect to the benefits of owning CIG PANNONIA security.